CINF
51
4
FTI
76
3
APH
67
3
CAT
62
7
NWS
69
7
HD
55
8
KMI
69
2
IFF
56
3
UA
59
14
HAL
60
2
LMT
32
-12
UNP
45
6
MDLZ
36
2
GS
73
7
PAYX
51
4
INTU
54
3
PSA
56
5
STI
31
-16
TXT
52
4
AAL
53
-4
CINF
51
4
FTI
76
3
APH
67
3
CAT
62
7
NWS
69
7
HD
55
8
KMI
69
2
IFF
56
3
UA
59
14
HAL
60
2
LMT
32
-12
UNP
45
6
MDLZ
36
2
GS
73
7
PAYX
51
4
INTU
54
3
PSA
56
5
STI
31
-16
TXT
52
4
AAL
53
-4
Financhill
Back

Entrada Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison

Buy
58

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-29.61%
Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
450.53
Seasonality Move:
11.1%
Buy
58
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.05. The Score for TRDA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $450.37. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $450.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 50.91 Buy
Chaikin Money Flow: 10625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.97 Sell
Relative Strength Index (14 RSI): 37.76 Sell
Chaikin Money Flow: 44374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.48 Sell
20-day SMA: 18.27 Sell
50-day SMA: 16.93 Buy
200-day SMA: 15.19 Buy
8-day EMA: 18.24 Sell
20-day EMA: 18.15 Sell
50-day EMA: 17.37 Buy
200-day EMA: 15.84 Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 468.86 Sell
20-day SMA: 479.26 Sell
50-day SMA: 474.44 Sell
200-day SMA: 453.81 Sell
8-day EMA: 465.05 Sell
20-day EMA: 474.27 Sell
50-day EMA: 475.71 Sell
200-day EMA: 452.67 Sell

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.25 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):